Reduced asymmetric dimethylarginine (ADMA) levels mediate in the protection from metabolic syndrome by smoking

被引：6
|
作者：
Onat, Altan [2 ]
Hergenc, Guelay [1 ]
机构：
[1] Yildiz Tech Univ, Dept Biol, Istanbul, Turkey
[2] Istanbul Univ, Cerrahpasa Med Fac, Istanbul, Turkey
来源：
ATHEROSCLEROSIS | 2008年 / 196卷 / 01期
关键词：
asymmetric dimethylarginine; cigarette smoking; insulin resistance; metabolic syndrome; obesity;
D O I：
10.1016/j.atherosclerosis.2006.10.040
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：479 / 480
页数：2
相关论文
共 50 条
  • [21] Asymmetric dimethylarginine levels and carotid intima-media thickness in obese patients with polycystic ovary syndrome and their relationship metabolic parameters
    Pamuk, Baris Onder
    Torun, Ayse Nur
    Kulaksizoglu, Mustafa
    Ertugrul, Derun
    Ciftci, Ozgur
    Kulaksizoglu, Sevsen
    Yildirim, Erkan
    Demirag, Nilgun Guvener
    FERTILITY AND STERILITY, 2010, 93 (04) : 1227 - 1233
  • [22] Plasma asymmetric dimethylarginine (ADMA) levels and atherosclerotic disease in ankylosing spondylitis: a cross-sectional study
    Gian Luca Erre
    Pietro Sanna
    Angelo Zinellu
    Alessandra Ponchietti
    Patrizia Fenu
    Salvatore Sotgia
    Ciriaco Carru
    Antonello Ganau
    Giuseppe Passiu
    Clinical Rheumatology, 2011, 30 : 21 - 27
  • [23] Monitorization of Asymmetric Dimethylarginine (ADMA) Levels in an Experimental Ischemia-Reperfusion Flap Model: A Preliminary Report
    Karaaslan, Onder
    Sonmez, Erhan
    Kankaya, Yuksel
    Silistreli, Ozlem Karatas
    Can, Murat Melih
    Bedir, Yagmur Kaan
    Caliskan, Gorkem
    JOURNAL OF RECONSTRUCTIVE MICROSURGERY, 2013, 29 (06) : 417 - 420
  • [24] Plasma asymmetric dimethylarginine (ADMA) levels and atherosclerotic disease in ankylosing spondylitis: a cross-sectional study
    Erre, Gian Luca
    Sanna, Pietro
    Zinellu, Angelo
    Ponchietti, Alessandra
    Fenu, Patrizia
    Sotgia, Salvatore
    Carru, Ciriaco
    Ganau, Antonello
    Passiu, Giuseppe
    CLINICAL RHEUMATOLOGY, 2011, 30 (01) : 21 - 27
  • [25] Asymmetric dimethylarginine (ADMA): a potential link between endothelial dysfunction and cardiovascular diseases in insulin resistance syndrome?
    Chan, NN
    Chan, JCN
    DIABETOLOGIA, 2002, 45 (12) : 1609 - 1616
  • [26] Correlation of Macrophage Migration Inhibitory Factor (MIF) Expression and Asymmetric Dimethylarginine (ADMA) Levels in Helicobacter pylori Infection
    Yulizal, O. K.
    Lelo, Aznan
    Ilyas, Syafruddin
    Kusumawati, Raden Lia
    PROCEEDINGS OF 2020 12TH INTERNATIONAL CONFERENCE ON BIOINFORMATICS AND BIOMEDICAL TECHNOLOGY, ICBBT 2020, 2020, : 134 - 138
  • [27] Asymmetric Dimethylarginine (ADMA) in Pediatric Renal Diseases: From Pathophysiological Phenomenon to Clinical Biomarker and Beyond
    Hsu, Chien-Ning
    Tain, You-Lin
    CHILDREN-BASEL, 2021, 8 (10):
  • [28] Lack of correlation between plasma asymmetric dimethylarginine (ADMA) levels and pain-related behaviors in neuropathic rats
    Hafizoglu, Emin
    Ulugol, Ahmet
    NEUROLOGY PSYCHIATRY AND BRAIN RESEARCH, 2011, 17 (04) : 79 - 83
  • [29] Plasma asymmetric dimethylarginine (ADMA) levels in Mexican women exposed to polycyclic aromatic hydrocarbons (PAHs): A preliminary study
    Pruneda-Alvarez, Lucia G.
    Ruiz-Vera, Tania
    Ochoa-Martinez, Angeles C.
    Perez-Vazquez, Francisco J.
    Gonzalez Palomo, Ana K.
    Ilizaliturri-Hernandez, Cesar A.
    Perez-Maldonado, Ivan N.
    SCIENCE OF THE TOTAL ENVIRONMENT, 2016, 572 : 1195 - 1202
  • [30] Asymmetric dimethylarginine (ADMA): the silent transition from an 'uraemic toxin' to a global cardiovascular risk molecule
    Fliser, D
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2005, 35 (02) : 71 - 79
12345